BioCentury | Apr 24, 2018
Distillery Therapeutics

Cancer

...have AUTO6 (1RG-CART), anti-GD2 CAR transduced T cells, in Phase I testing for neuroblastoma. Beijing Sinobioway Group...
BioCentury | Apr 16, 2018
Preclinical News

Anti-GD2 CAR T could treat midline gliomas

...on Tuesday. Autolus has worldwide, commercialization rights to the therapy from University College London. Beijing Sinobioway Group...
...T cells in Phase I/II testing to treat refractory or relapsed neuroblastoma. Chris Lieu Autolus Therapeutics plc Beijing Sinobioway Group...
BioCentury | Sep 21, 2017
Translation in Brief

Driving CARs into neuroblastoma

...L1 cell adhesion molecule ( L1CAM ; CD171), while those from Autolus Ltd. and Beijing Sinobioway Group...
BioCentury | Aug 11, 2017
Company News

Sinobioway provides update on its bid to acquire Sinovac

...B, primarily in China. Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Business: Infectious Alex Himes Sinovac Biotech Ltd. Beijing Sinobioway Group...
BioCentury | Jul 3, 2017
Company News

Sinobioway counters Sinovac buyout offer

...in China. Sinobioway Biomedicine is an affiliate of Beijing Sinobioway Group Co. Ltd. (Beijing, China). Alicia Parker Beijing Sinobioway Group...
BioCentury | Jun 26, 2017
Financial News

Sinovac going private

...a $7 per share offer from a consortium of Chinese companies. The group included Beijing Sinobioway Group...
BioCentury | May 26, 2017
Company News

BioAtla, Beijing Sinobioway expand CAB deal

...BioAtla LLC (San Diego, Calif.) and Beijing Sinobioway Group Ltd. (Beijing, China) added five products from BioAtla's...
...LLC , San Diego, Calif. Beijing Sinobioway Group Co. Ltd. , Beijing, China Business: Cancer Alicia Parker Beijing Sinobioway Group...
BioCentury | Jan 6, 2017
Financial News

F1 Oncology completes venture financing

...F1 Oncology raised $37 million in a series A round from F1 BioVentures, Sinobioway Group and SunTerra...
BioCentury | Feb 8, 2016
Company News

Sinovac deal

...Co. Ltd., Shandong Sinobioway Biomedicine Co. Ltd., CICC Qianhai Development Fund Management Co. Ltd., Beijing Sinobioway Group...
BioCentury | Feb 1, 2016
Company News

BioAtla, Beijing Sinobioway deal

...terms, and Sinobioway did not respond to inquiries. BioAtla LLC , San Diego, Calif. Beijing Sinobioway Group...
Items per page:
1 - 10 of 10
BioCentury | Apr 24, 2018
Distillery Therapeutics

Cancer

...have AUTO6 (1RG-CART), anti-GD2 CAR transduced T cells, in Phase I testing for neuroblastoma. Beijing Sinobioway Group...
BioCentury | Apr 16, 2018
Preclinical News

Anti-GD2 CAR T could treat midline gliomas

...on Tuesday. Autolus has worldwide, commercialization rights to the therapy from University College London. Beijing Sinobioway Group...
...T cells in Phase I/II testing to treat refractory or relapsed neuroblastoma. Chris Lieu Autolus Therapeutics plc Beijing Sinobioway Group...
BioCentury | Sep 21, 2017
Translation in Brief

Driving CARs into neuroblastoma

...L1 cell adhesion molecule ( L1CAM ; CD171), while those from Autolus Ltd. and Beijing Sinobioway Group...
BioCentury | Aug 11, 2017
Company News

Sinobioway provides update on its bid to acquire Sinovac

...B, primarily in China. Sinovac Biotech Ltd. (NASDAQ:SVA), Beijing, China Business: Infectious Alex Himes Sinovac Biotech Ltd. Beijing Sinobioway Group...
BioCentury | Jul 3, 2017
Company News

Sinobioway counters Sinovac buyout offer

...in China. Sinobioway Biomedicine is an affiliate of Beijing Sinobioway Group Co. Ltd. (Beijing, China). Alicia Parker Beijing Sinobioway Group...
BioCentury | Jun 26, 2017
Financial News

Sinovac going private

...a $7 per share offer from a consortium of Chinese companies. The group included Beijing Sinobioway Group...
BioCentury | May 26, 2017
Company News

BioAtla, Beijing Sinobioway expand CAB deal

...BioAtla LLC (San Diego, Calif.) and Beijing Sinobioway Group Ltd. (Beijing, China) added five products from BioAtla's...
...LLC , San Diego, Calif. Beijing Sinobioway Group Co. Ltd. , Beijing, China Business: Cancer Alicia Parker Beijing Sinobioway Group...
BioCentury | Jan 6, 2017
Financial News

F1 Oncology completes venture financing

...F1 Oncology raised $37 million in a series A round from F1 BioVentures, Sinobioway Group and SunTerra...
BioCentury | Feb 8, 2016
Company News

Sinovac deal

...Co. Ltd., Shandong Sinobioway Biomedicine Co. Ltd., CICC Qianhai Development Fund Management Co. Ltd., Beijing Sinobioway Group...
BioCentury | Feb 1, 2016
Company News

BioAtla, Beijing Sinobioway deal

...terms, and Sinobioway did not respond to inquiries. BioAtla LLC , San Diego, Calif. Beijing Sinobioway Group...
Items per page:
1 - 10 of 10